The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

被引：0
作者：
S P R Romaine
K M Bailey
A S Hall
A J Balmforth
机构：
[1] Leeds Institute of Genetics,Division of Cardiovascular and Diabetes Research
[2] Health and Therapeutics,undefined
[3] University of Leeds,undefined
[4] Multidisciplinary Cardiovascular Research Centre (MCRC),undefined
[5] Leeds Institute of Genetics,undefined
[6] Health and Therapeutics,undefined
[7] University of Leeds,undefined
来源：
The Pharmacogenomics Journal | 2010年 / 10卷
关键词：
cholesterol; myopathy; polymorphism; statin; transporter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are well established in the treatment of hypercholesterolaemia and the prevention of coronary artery disease. Despite this, there is wide inter-individual variability in response to statin therapy, in terms of both lipid-lowering and adverse drug reactions. The major site of statin action is within hepatocytes and recent interest has focussed on genetic variation in hepatic influx and efflux transporters for their potential to explain these differences. In this review we explore current literature regarding the pharmacokinetic and pharmacodynamic influence of the common c.388A>G and c.521T>C single-nucleotide polymorphisms (SNPs) within the solute carrier organic anion transporter 1B1 (SLCO1B1) gene, encoding the organic anion transporter polypeptide 1B1 (OATP1B1) influx transporter. We discuss their potential to predict the efficacy of statin therapy and the likelihood that patients will experience adverse effects.
引用
收藏
页码：1 / 11
页数：10
相关论文
共 50 条
[31]   A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance [J].
Bigossi, Margherita ;
Maroteau, Cyrielle ;
Dawed, Adem Y. ;
Taylor, Alasdair ;
Srinivasan, Sundararajan ;
Melhem, Alaa' Lufti ;
Pearson, Ewan R. ;
Pola, Roberto ;
Palmer, Colin N. A. ;
Siddiqui, Moneeza K. .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (06) :536-545
[32]   Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1*15 and OATP1B3 [J].
van de Steeg, E. ;
Venhorst, J. ;
Jansen, H. T. ;
Nooijen, I. H. G. ;
DeGroot, J. ;
Wortelboer, H. M. ;
Vlaming, M. L. H. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 70 :29-36
[33]   Association of SLCO1B1 Polymorphisms and Atorvastatin Safety and Efficacy: A Meta-analysis [J].
Du, Yaming ;
Wang, Sizheng ;
Chen, Zhangyong ;
Sun, Shusen ;
Zhao, Zhigang ;
Li, Xingang .
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (34) :4044-4050
[34]   Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China [J].
Zhong, Zhixiong ;
Wu, Heming ;
Li, Bin ;
Li, Cunren ;
Liu, Zhidong ;
Yang, Min ;
Zhang, Qifeng ;
Zhong, Wei ;
Zhao, Pingsen .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (06)
[35]   Clinical Importance of OATP1B1 and OATP1B3 in Drug-Drug Interactions [J].
Shitara, Yoshihisa .
DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (03) :220-227
[36]   Analysis of APOE and SLCO1B1 Gene Polymorphism and Correlation with Dyslipidemia in China [J].
Long, Lu ;
Sun, Qian .
CLINICAL LABORATORY, 2022, 68 (11) :2310-2315
[37]   Polymorphisms of the SLCO1B1 Gene Predict Methotrexate-Related Toxicity in Childhood Acute Lymphoblastic Leukemia [J].
Lopez-Lopez, Elixabet ;
Martin-Guerrero, Idoia ;
Ballesteros, Javier ;
Angeles Pinan, M. ;
Garcia-Miguel, Purificacion ;
Navajas, Aurora ;
Garcia-Orad, Africa .
PEDIATRIC BLOOD & CANCER, 2011, 57 (04) :612-619
[38]   Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics [J].
Wagner, Jonathan B. ;
Abdel-Rahman, Susan ;
Van Haandel, Leon ;
Gaedigk, Andrea ;
Gaedigk, Roger ;
Raghuveer, Geetha ;
Kauffman, Ralph ;
Leeder, J. Steven .
JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (06) :823-833
[39]   Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients [J].
Guo-ping Yang ;
Hong Yuan ;
Bin Tang ;
Wei Zhang ;
Lian-sheng Wang ;
Zhi-jun Huang ;
Dong-sheng Ou-Yang ;
Gui-xiang Zhang ;
Hong-hao Zhou .
Acta Pharmacologica Sinica, 2010, 31 :382-386
[40]   Lack of effect of genetic polymorphisms of SLCO1B1 on the lipid-lowering response to pitavastatin in Chinese patients [J].
Yang, Guo-ping ;
Yuan, Hong ;
Tang, Bin ;
Zhang, Wei ;
Wang, Lian-sheng ;
Huang, Zhi-jun ;
Ou-Yang, Dong-sheng ;
Zhang, Gui-xiang ;
Zhou, Hong-hao .
ACTA PHARMACOLOGICA SINICA, 2010, 31 (03) :382-386
12345